|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: TEXAS BIOTECHNOLOGY CORP /DE/, 10-Q, EX-3.8, 2000-08-14 |
Next: TEXAS BIOTECHNOLOGY CORP /DE/, 10-Q, EX-99.4, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> APR-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 24,041,853
<SECURITIES> 53,497,859
<RECEIVABLES> 12,687,129
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 83,465,756
<PP&E> 9,735,563
<DEPRECIATION> (7,167,838)
<TOTAL-ASSETS> 91,650,443
<CURRENT-LIABILITIES> 2,749,858
<BONDS> 0
0
0
<COMMON> 204,034
<OTHER-SE> 88,900,585
<TOTAL-LIABILITY-AND-EQUITY> 91,650,443
<SALES> 0
<TOTAL-REVENUES> 12,376,411
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 6,378,882
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 5,997,529
<INCOME-TAX> 0
<INCOME-CONTINUING> 5,997,529
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 5,997,529
<EPS-BASIC> 0.15
<EPS-DILUTED> 0.14
</TABLE>
|
|